CHARLOTTE, N.C., March 24 /PRNewswire-FirstCall/ -- MedCath Corporation
(MedCath) (Nasdaq: MDTH), its physician partners and Good Samaritan Hospital
(Dayton, Ohio) jointly announced today that the parties have entered into a
definitive agreement pursuant to which Good Samaritan Hospital will acquire
substantially all of Dayton Heart Hospital's assets. The total amount being
paid is approximately $55.0 million, a portion of which is allocated to
customary non-competition obligations. The transaction is expected to close on
or about May 16, subject to customary closing conditions.
Net proceeds to MedCath, after estimated income tax related to the gain on
sale, are anticipated to total approximately $32.5 million. MedCath will use
the proceeds for general corporate purposes, including investment in other
hospital projects. Beginning with its second quarter of fiscal 2008, which
ends March 31, MedCath will account for Dayton Heart Hospital as an asset
held-for-sale for the current and prior reporting periods.
Opened in 1999, Dayton Heart Hospital is a 47-bed hospital focused on
providing cardiovascular care to the Dayton community. A member of the Premier
Health Partners system, Good Samaritan Hospital (Dayton, Ohio) is a 577-bed,
full-service teaching facility with a 75-year history that delivers best-in-
care cardiovascular, cancer and orthopedics services. Recently, the Joint
Commission awarded gold seal certifications to the hospital's outstanding
heart failure, heart attack, breast cancer and artery bypass graft surgery
programs. Additionally, HealthGrades, the leading independent quality
monitoring organization in the country, named Good Samaritan as a recipient of
its 2008 Distinguished Hospital Award for Clinical Excellence, which places it
among the top 5 percent of hospitals nationwide.
"We've had a successful engagement with physician partners in Dayton and
have changed the landscape for delivery of heart services in Central Ohio,
typical of what happens when MedCath teams up with doctors to raise the bar
for hospital care. As we continue to evolve MedCath, focusing on future
expansion in markets that equal or exceed national population growth rates is
high on our list of preferences," said O.
Edwin French, MedCath's President
and Chief Executive Officer. He added, "This transaction furthers enhances
our already-strong balance sheet so that our foray into acquired acute care
hospitals is enhanced. And, with this transaction we also continue to shift
the mix of business within our portfolio as we expand heart care but expand
the ratio of diversified services faster."
MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare
provider focused on high acuity services with the diagnosis and treatment of
cardiovascular disease being a primary service offering. Following completion
of the divestiture of Dayton Heart Hospital, MedCath will own an interest in
and operate nine hospitals with a total of 616 licensed beds, located in
Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas.
MedCath is in the process of developing its tenth hospital, which is
anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and
its subsidiary MedCath Partners provide services in diagnostic and therapeutic
facilities in various states.
Parts of this announcement contain forward-looking statements that involve
risks and uncertainties, including the closing of an anticipated sale of the
assets of Dayton Heart Hospital. Although management believes that these
forward-looking statements are based on reasonable assumptions, these
assumptions are inherently subject to significant economic, regulatory and
competitive uncertainties and contingencies that are difficult or impossible
to predict accurately and are beyond our control. Actual results could differ
materially from those projected in these forward-looking statements. We do not
assume any obligation to update these statements in a news release or
otherwise should material facts or circumstances change in ways that would
affect their accuracy.
These various risks and uncertainties are described in detail in "Risk
Factors" in MedCath's Form 10-K filed with the Securities and Exchange
Commission on December 14, 2007, a copy of which is available on the internet
site of the Securities and Exchange Commission at http://www.sec.gov.